What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Enzyme
Ton J. Rabelink mainly focuses on Internal medicine, Endocrinology, Endothelium, Nitric oxide and Endothelial dysfunction.
His Internal medicine study combines topics from a wide range of disciplines, such as Diabetes mellitus, Type 2 diabetes and Cardiology.
His research investigates the link between Endocrinology and topics such as CTGF that cross with problems in Fibrosis.
His Endothelium research includes elements of Endothelial stem cell and Inflammation, Immunology, Cell adhesion molecule, Monocyte.
His Nitric oxide study incorporates themes from Oxidative stress, Biochemistry, In vivo and Endothelin receptor.
Ton J. Rabelink has included themes like Flow-Mediated Vasodilation, Angiotensin-converting enzyme, ACE inhibitor, Omega-N-Methylarginine and Angiotensin II in his Endothelial dysfunction study.
His most cited work include:
- Endothelial Function and Dysfunction Testing and Clinical Relevance (1918 citations)
- Endothelial Progenitor Cell Dysfunction: A Novel Concept in the Pathogenesis of Vascular Complications of Type 1 Diabetes (760 citations)
- Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. (545 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Endocrinology, Immunology, Endothelium and Kidney.
His research investigates the connection with Internal medicine and areas like Cardiology which intersect with concerns in Asymptomatic.
His works in Nitric oxide, Insulin resistance, Vasodilation, Postprandial and Blood pressure are all subjects of inquiry into Endocrinology.
Ton J. Rabelink has researched Nitric oxide in several fields, including Biochemistry and Superoxide.
His research in Endothelium intersects with topics in Endothelial stem cell, Inflammation, Vascular disease and Cell biology.
Ton J. Rabelink combines subjects such as Transplantation and Pathology with his study of Kidney.
He most often published in these fields:
- Internal medicine (55.74%)
- Endocrinology (34.78%)
- Immunology (13.48%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (55.74%)
- Cell biology (12.31%)
- Kidney (13.31%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Cell biology, Kidney, Immunology and Neutrophil extracellular traps.
His Internal medicine research is multidisciplinary, incorporating elements of Diabetes mellitus, Endocrinology and Gastroenterology.
In his study, which falls under the umbrella issue of Endocrinology, Podocyte is strongly linked to Heparanase.
His studies deal with areas such as Endothelial stem cell, Endothelium and Induced pluripotent stem cell as well as Cell biology.
The Kidney study combines topics in areas such as Pathology, Stromal cell, Mesenchymal stem cell, Cancer research and Transplantation.
He has researched Neutrophil extracellular traps in several fields, including ANCA-Associated Vasculitis, Myeloperoxidase and Pathogenesis.
Between 2015 and 2021, his most popular works were:
- Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy (251 citations)
- Renal Subcapsular Transplantation of PSC-Derived Kidney Organoids Induces Neo-vasculogenesis and Significant Glomerular and Tubular Maturation In Vivo. (129 citations)
- The MEST score provides earlier risk prediction in lgA nephropathy (114 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Enzyme
Ton J. Rabelink focuses on Internal medicine, Kidney, Cell biology, Immunology and Diabetic nephropathy.
His Internal medicine study typically links adjacent topics like Endocrinology.
His studies in Endocrinology integrate themes in fields like Outpatient clinic and Lumbar vertebrae.
His Kidney research includes themes of Cancer research, microRNA, Vascular endothelial growth factor and Pathology.
His Cell biology study combines topics in areas such as Endothelial stem cell, Transcriptome, Angiogenesis and Protein Quaking.
His Diabetic nephropathy research incorporates elements of Heparanase, Glomerulosclerosis, Albuminuria and Glycocalyx.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
